Guidelines International Network | Guidelines International Network (GIN)

生物制剂感染并发症处理指南

MeSH Terms: Control Agents, Biological；Biological Control Agent；Infections；Meta-Analysis as Topic; Systematic Reviews as Topic; Controlled Clinical Trials as Topic; Random Allocation; Double-Blind Method; single-blind method; Control Groups; cross-over studies; guidline
Guideline Contact: Xiaojun Ma：[email protected]
English Title Translation: Guidelines for the Management of Complications Caused by Biological Agents Infection
Keywords: Biological Agents, Infection, Complications,
Methods Applied: Oxford Center for Evidence-based Medicine, OCEBM Levels of Evidence; Grading of recommendations assessment，development and evaluation，GRADE; Best practice statement, BPS
Publication Scope: Management; Patient Education; Prevention; Treatment; screening
Countries of Application: China
Guideline Publication Status: Development
Languages: Chinese
Authors: Xiaojun Ma
Willingness to Collaborate: Yes
Name of Endorsing Organization: 中国研究型医院学会感染性疾病循证与转化专业委员会 Infectious Diseases Society for Evidence-based and Translational Medicine of Chinese Research Hospital Association

MeSH Terms: Carbapenem-Resistant Pseudomonas aeruginosa; Gram-Negative Bacterial Infections; Controlled Clinical Trials as Topic; Random Allocation; Double-Blind Method; single-blind method; Control Groups; cross-over studies; Meta-Analysis as Topic; Systematic Reviews as Topic;
Guideline Contact: Yunsong Yu, [email protected]
English Title Translation: Guidelines for diagnosis and treatment of carbapenem-resistant Pseudomonas aeruginosa infection
Keywords: Carbapenem resistant Organism; Diagnosis; Treatment; Prevention; Evidence-based guidleine
Date for Review: 31/12/2026
Expected Publication Date: 31/12/2025
Date of Last Evidence Search: 11/02/2025
Methods Applied: delphi technique; systematic review; Evidence synthesis; GRADE assessment of quality of evidence; GRADE evidence to decision framework;
Publication Scope: Diagnosis, Treatment and Prevention
Countries of Application: China
Guideline Publication Status: Development
Languages: Chinese; English
Authors: Dr Yunsong Yu
Willingness to Collaborate: Yes

MeSH Terms: Multiple Myeloma; NDMM; prognostic model; Daratumumab; Isatuximab; Autografting; MRD; Immunotherapy
Guideline Contact: [email protected]
English Title Translation: The treatment guidelines for high-risk multiple myeloma
Keywords: NDMM; prognostic model; Daratumumab; Isatuximab; MRD; Autografting; Immunotherapy
Date for Review: 30/6/2030
Expected Publication Date: 30/6/2026
Date of Last Evidence Search: 30/11/2025
Publication Scope: assessment; prognosis; treatment
Countries of Application: China
Guideline Publication Status: Development
Languages: English
Authors: 邱录贵; 马军
Willingness to Collaborate: Yes